We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

75 hedge funds and large institutions have $265M invested in Accelerate Diagnostics in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

388% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 8

380% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 5

37% more capital invested

Capital invested by funds: $194M → $265M (+$71.9M)

34% more funds holding

Funds holding: 56 → 75 (+19)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

44% less call options, than puts

Call options by funds: $3.68M | Put options by funds: $6.53M

Holders
75
Holders Change
+19
Holders Change %
+33.93%
% of All Funds
2.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
39
Reduced
8
Closed
5
Calls
$3.68M
Puts
$6.53M
Net Calls
-$2.85M
Net Calls Change
-$2.4M

Top Buyers

1
OIM
Oracle Investment Management
Connecticut
+$13.4M
2
SCM
Sandler Capital Management
New York
+$4.37M
3
BFA
BlackRock Fund Advisors
California
+$4.11M
4
BIT
BlackRock Institutional Trust
California
+$3.67M
5
State Street
State Street
Massachusetts
+$3.48M

Top Sellers

1
Invesco
Invesco
Georgia
-$12.7M
2
Goldman Sachs
Goldman Sachs
New York
-$2.51M
3
HCS
Harvest Capital Strategies
California
-$1.2M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$377K
5
BWP
BSW Wealth Partners
Colorado
-$240K
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$902K +$753K +3,452 +19,178%
Morgan Stanley
27
Morgan Stanley
New York
$838K +$167K +765 +31%
TA
28
Teachers Advisors
New York
$814K +$292K +1,336 +74%
BWP
29
BSW Wealth Partners
Colorado
$747K -$240K -1,100 -28%
FBC
30
Fairfield, Bush & Co
Connecticut
$718K +$603K +2,763 New
Swiss National Bank
31
Swiss National Bank
Switzerland
$653K +$548K +2,510 New
Deutsche Bank
32
Deutsche Bank
Germany
$624K +$421K +1,929 +404%
CI
33
Chartist Inc
California
$564K +$28.8K +132 +6%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$471K +$395K +1,810 New
CCM
35
Coe Capital Management
Illinois
$464K +$171K +783 +78%
MLICM
36
Metropolitan Life Insurance Company (MetLife)
New York
$463K +$175K +803 +82%
NFA
37
Nationwide Fund Advisors
Ohio
$453K +$195K +893 +105%
William Blair & Company
38
William Blair & Company
Illinois
$444K +$137K +628 +58%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$424K +$356K +1,632 New
GA
40
Geneva Advisors
Illinois
$408K +$41.9K +192 +14%
MCC
41
Mid Continent Capital
Illinois
$397K -$14.8K -68 -4%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$395K +$127K +580 +62%
AIG
43
American International Group
New York
$386K +$160K +732 +97%
SO
44
STRS Ohio
Ohio
$367K +$214K +980 +228%
FAAS
45
First Allied Advisory Services
California
$344K +$288K +1,318 New
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$324K +$272K +1,244 New
VOYA Investment Management
47
VOYA Investment Management
Georgia
$318K +$267K +1,223 New
ProShare Advisors
48
ProShare Advisors
Maryland
$288K -$3.27K -15 -1%
BF
49
BOK Financial
Oklahoma
$286K +$21.4K +98 +10%
BA
50
BlackRock Advisors
Delaware
$249K +$83.6K +383 +66%
1
2
3 4

AXDX Hedge Fund Activity: Q2 2014 in Review

75 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q2 2014, worth a combined $265M — up 37% from $194M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AXDX positions and 5 closed out — a net gain of 19 holders — while 39 added to existing stakes and 8 trimmed.

The largest buyer was Oracle Investment Management, adding an estimated $13.4M. The largest seller was Invesco, exiting entirely with an estimated $12.7M sold.

  • 75 institutional investors held Accelerate Diagnostics (AXDX) as of Q2 2014, up from 56 in Q1 2014.
  • Funds reported $265M of Accelerate Diagnostics stock for Q2 2014, up 37% quarter-over-quarter.
  • 24 funds opened new Accelerate Diagnostics positions in Q2 2014 and 5 closed out, a net change of +19 holders.
  • The largest Accelerate Diagnostics buyer in Q2 2014 was Oracle Investment Management, an estimated $13.4M added.
  • The largest Accelerate Diagnostics seller in Q2 2014 was Invesco, an estimated $12.7M sold.

Based on aggregated 13F filings for Q2 2014.